BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Europabio - ECPv6.17.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Europabio
X-ORIGINAL-URL:https://www.europabio.org
X-WR-CALDESC:Events for Europabio
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260930T110000
DTEND;TZID=Europe/Brussels:20260930T133000
DTSTAMP:20260901T091358Z
CREATED:20260901T091316Z
LAST-MODIFIED:20260901T091358Z
UID:9749-1790766000-1790775000@www.europabio.org
SUMMARY:Draghi Needs Friends - How to Keep Biotech Scaling in Europe
DESCRIPTION:Hosted by Regina Doherty MEP (EPP\, Ireland). Organised by BioPharmaChem Ireland and EuropaBio \n\n\n\nWhy now. European biotech companies still cross the Atlantic to scale; for late-stage capital\, for listings\, or through an acquisition that arrives too early. Meanwhile\, the competition is moving. China’s 15th Five-Year Plan for 2026 to 2030 names life science and biotechnology among eight frontier technologies targeted for breakthrough\, identifies biomanufacturing as a priority for industrial upgrading\, and sets a research and development expenditure target above 3.2% of gross domestic product.The European political framework is open at the same time. The Biotech Act is in negotiation as two instruments\, a Regulation and a Directive\, both tabled in December 2025. EU Inc. was proposed in March 2026\, and the Commission is urging Parliament and Council to agree by the end of 2026. On the financing side\, Europe is still working in delivering the Savings and Investments Union and negotiating the next Multi-Financial Framework. Biotech Act II\, covering industrial biotechnology and biomanufacturing\, follows. \n\n\n\nSession 1\, 11.05 to 11.50 – The gap\, the instruments\, and what investors look for \n\n\n\nSession 2\, 12.05 to 12.50. Draghi needs friends: why are we stuck\, and what moves first? \n\n\n\nSpace for this event is limited\, therefore attendance is not guaranteed\, confirmation of attendance will be sent via email closer to the date of the event. \n\n\n\n\nRegister Interest Here
URL:https://www.europabio.org/event/draghi-needs-friends-how-to-keep-biotech-scaling-in-europe/
CATEGORIES:Biomanufacturing Platform,Biotech Week,EuropaBio,Healthcare Biotech,Industrial Biotech,National Associations,SME Platform
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/09/Event-Banner-Irish-Presidency-Summit.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20261026T080000
DTEND;TZID=Europe/Brussels:20261028T200000
DTSTAMP:20260219T132456Z
CREATED:20260219T132453Z
LAST-MODIFIED:20260219T132456Z
UID:9482-1793001600-1793217600@www.europabio.org
SUMMARY:World Orphan Drug Congress 2026
DESCRIPTION:The World Orphan Drug Congress Europe is the largest and most established event globally for orphan drugs and rare diseases. \n\n\n\nJoin over 1\,800 senior industry leaders\, gain insights from 250+ expert speakers\, and connect with over 100 exhibitors driving progress across the entire orphan drug lifecycle. From regulatory strategy and market access to patient engagement and the latest breakthroughs in gene and cell therapies\, the congress delivers practical insights you can apply immediately. \n\n\n\nNetwork with the most senior individuals across the industry\, including leaders in R&D\, gene therapy\, rare diseases\, precision/personalised medicine\, genetic disorders\, patient advocacy and engagement\, associations in ATMPs\, investors\, regulatory affairs professions\, governmental bodies\, and more… \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/world-orphan-drug-congress-2026/
CATEGORIES:External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/02/Event-Banners-Website-42.png
END:VEVENT
END:VCALENDAR